MANUFACTURERS PUNISHED FOR EXCESSIVE DRUG PRICES: British regulator publishes list of companies, here’s how much they will pay arrogance

The British regulatory body announced that it had fined a group of drug manufacturers in the total amount of slightly more than 260 million pounds (360 million dollars) due to the high prices of hydrocortisone that they charged to the health system.

MANUFACTURERS PUNISHED FOR EXCESSIVE DRUG PRICES: British regulator publishes list of companies, here's how much they will pay arrogance

Photo: Depositphotos

The regulator has fined Actavis UK, Auden McKenzie, Allergan Plc, Accord Healthcare, Intas Pharmaceuticals, Waymade Plc, Amdipharm, Advanz Pharma and some Cinvena companies.

The largest fine will be paid by the companies “Auden Mckenzie” and “Actavis UK”, in the amount of 221.1 million pounds.

The companies charged the state health system (NHS) “excessively high prices” for steroid hydrocortisone, which is used as a replacement therapy when the adrenal glands do not produce enough cortisone, the regulator explained on Thursday.

Companies also occasionally bought potential competitors, in order to prevent their entry into the health market. In addition, they raised drug prices as the sole suppliers and bribed remaining competing companies.

– It was a gross violation of the law, as well as charging excessive costs to the NHS. As a result, the funds for the treatment of patients were reduced – the executive director of the CMA, Andrea Kosceli, emphasized.

The mentioned companies were not available for comment on the statement of the executive director.

(Jutarnji list)

Follow us through iOS and android apps

CLICK FOR MORE NEWS

Source: Novosti.rs RSS – Današnje vesti by www.novosti.rs.

*The article has been translated based on the content of Novosti.rs RSS – Današnje vesti by www.novosti.rs. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!